Argis İlaç

  • English
  • Türkçe
  • HOME
  • ABOUT US
  • NEWS
  • PRODUCTS
    • DRUGS
    • FOOD SUPPLEMENTS
  • HUMAN RESOURCES
    • HR PRINCIPLES
    • HR PRACTICES
  • REFERENCE
  • SERVICES
  • COMMUNICATION

250 Largest Companies By R & D Spending 2019

Thursday, 22 October 2020 by mustafa

According to the research of R & D companies conducted by Turkishtime magazine, our company took its place in the top ranks in 2019, as in 2018

250 Largest Companies By R & D Spending 2019

  1. sırada

2019 Top 100 according to number of projects carried out in R & D Center

in order
As Argis ilaç, we continue to produce projects by conducting research and development for our country.
http://www.turkishtimedergi.com/arge250/index.html

Read more
  • Published in Uncategorized
No Comments

Together with our Board of directors and all our employees, We celebrated the license of our D3 TOTAL 150,000 IU/10ML ORAL Drops, solution product

Monday, 16 December 2019 by mustafa
Read more
  • Published in Uncategorized
No Comments

Adverse Effect Notification

Tuesday, 10 December 2019 by mustafa

Side Effect/Adverse Reaction Notification:

For notifications of side effects/adverse reactions related to our products, you can consult your doctor or pharmacist, contact the authorized health authority, or fill out the form below (Tufam adverse reaction Notification Form pv@deltapv.com you can send it to his address.

In addition, you can contact us on 0216 385 93 33 for reports of side effects/adverse reactions.

Click here to download the Tufam adverse reaction Notification Form.

Instructions:

Notifications about side effects/adverse reactions are collected in accordance with legal obligations to benefit public health protection.
During the follow-up of notifications about side effects/adverse reactions, you can be returned to you using your contact information to obtain more information.
At least one of your phone or email address information must be notified so that we can get back to you.

Legal Notice:

All user information is confidential and, in accordance with the procedures set out in the relevant legislation, is not transferred to any person or company, except for institutions and organizations that need to be notified.

Read more
  • Published in haber
No Comments

R & D Center Certificate

Tuesday, 10 December 2019 by mustafa

In September 2018 as Argis Pharmaceuticals, t.C. We were declared as A R & D Center by the Ministry of industry and Technology. 7 on 19.11.2019. at the technology development zones and R & D center Award Ceremony held in si, we received our R & D Center certificate. At the 7th Summit, attended by Minister of industry and Technology Mustafa Varank, as well as senior managers of Ministry institutions and organizations, 39 companies in 13 different categories received awards and 735 companies received R & D and Design Center certificates.

Read more
  • Published in haber
No Comments

Turkey R & D Ranking

Tuesday, 10 December 2019 by mustafa

According to the research and Development Centers ranking study covering all sectors conducted by Turkishtime magazine,

Argis Pharmaceuticals:

15 by the number of br
http://turkishtimedergi.com/arge250/marka-ilk-50.html

19 according to the number of projects carried out.
http://turkishtimedergi.com/arge250/proje-ilk-100.html

25 according to the number of utility models received.
http://turkishtimedergi.com/arge250/faydali-model-ilk-50.html

37 according to the number of patents received.
http://turkishtimedergi.com/arge250/tasarim-tescil-ilk-50.html

37 according to the number of patents received.
http://turkishtimedergi.com/arge250/patent-ilk-50.html

has been. We continue to do research and development for our country.

Read more
  • Published in haber
No Comments

“Domestic” production in medicine

Monday, 09 December 2019 by mustafa
Turkey has taken a giant step in the pharmaceutical sector. Production of the first and only domestic drug has begun in the 2.5 billion pound biosimilar drug market. The drug aims to eliminate the side effects of chemotherapy.
Read more
  • Published in Uncategorized
No Comments

Adverse Effect Notification

Monday, 09 December 2019 by mustafa

Side Effect/Adverse Reaction Notification:

For notifications of side effects/adverse reactions related to our products, you can consult your doctor or pharmacist, contact the authorized health authority, or fill out the form below (Tufam adverse reaction Notification Form pv@deltapv.com you can send it to his address.

In addition, you can contact us on 0216 385 93 33 for reports of side effects/adverse reactions.

Click here to download the Tufam adverse reaction Notification Form.

Açıklamalar:

Notifications about side effects/adverse reactions are collected in accordance with legal obligations to benefit public health protection.
During the follow-up of notifications about side effects/adverse reactions, you can be returned to you using your contact information to obtain more information.
At least one of your phone or email address information must be notified so that we can get back to you.

Read more
  • Published in Uncategorized
No Comments

R & D Center Certificate

Monday, 09 December 2019 by mustafa

In September 2018 as Argis Pharmaceuticals, t.C. We were declared as A R & D Center by the Ministry of industry and Technology. 7 on 19.11.2019. at the technology development zones and R & D center Award Ceremony held in si, we received our R & D Center certificate. At the 7th Summit, attended by Minister of industry and Technology Mustafa Varank, as well as senior managers of Ministry institutions and organizations, 39 companies in 13 different categories received awards and 735 companies received R & D and Design Center certificates.

Read more
  • Published in Uncategorized
No Comments

Quick Menu

  • HOME
  • ABOUT US
  • NEWS
  • PRODUCTS
  • HUMAN RESOURCES
  • REFERENCE
  • SERVICES
  • COMMUNICATION

Corporate

  • ABOUT US
  • PATENTS & PUBLICATIONS
  • Certifications
  • HUMAN RESOURCES

Legal Notice

  • Privacy Statement

The information contained on this site is not a substitute for consulting a physician and pharmacist.

COMMUNICATION

  • Batı Sitesi Mah. Gersan Sanayi Sit.
    2307 Sok. No:80-82-84
    Ergazi Ankara / Türkiye
  • + 90 312 255 54 74
  • + 90 312 255 54 42
  • info@argisilac.com.tr
  • www.argisilac.com.tr

© 2014 Copyright. Copyright Reserved. Design by Ankara Web Tasarım

TOP